Z-2387-2021 Class II Terminated
FDA device recall Z-2387-2021 was initiated by Merge Healthcare, Inc. on Jul 23, 2021 and is designated Class II. Reason for recall: The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface. The recall status is terminated (terminated Aug 29, 2023). Affected quantity: 326 units.
Recall details
- Product Type
- Devices
- Report Date
- Sep 8, 2021
- Initiation Date
- Jul 23, 2021
- Termination Date
- Aug 29, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 326 units
Product description
Merge Hemo, Software packages 10.2, 10.3, and 10.4
Reason for recall
The firm identified a safety issue affecting the software associated with Merge Hemo versions 9.x and 10.x, used in combination with an HL7 lab interface.
Distribution pattern
US distribution
Code information
Version 10.2, UDI (01)00842000100430(10)10.2(11)190612 Version 10.3, UDI (01)00842000100874(10)10.3(11)200330 Version 10.4, UDI (01)00842000100966(10)10.4(11)210428
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2387-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026